Entity

Time filter

Source Type

Gaithersburg, MD, United States

Trademark
Sequoia Pharmaceuticals Inc. | Date: 2008-02-28

Biochemical compounds, namely, assays and reagents for research and development in the fields of pharmaceuticals; biochemicals for general manufacturing of a wide variety of goods; biometallic compounds for use in the manufacture of pharmaceuticals. Pharmaceutical preparations for the treatment of infectious diseases. Pharmaceutical, chemical and biological product research and development services; screening of pharmaceuticals for therapeutic efficacy; pharmaceutical, chemical and biological product development consultation services.


Patent
Sequoia Pharmaceuticals Inc | Date: 2014-12-09

Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Pharmaceutical compositions are provided that can act as boosters to improve the pharmacokinetics, enhance the bioavailability, and enhance the therapeutic effect of drugs that undergo in vivo degradation by cytochrome P450 enzymes.


Patent
Sequoia Pharmaceuticals Inc. | Date: 2011-11-01

Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Pharmaceutical compositions are provided that can act as boosters to improve the pharmacokinetics, enhance the bioavailability, and enhance the therapeutic effect of drugs that undergo in vivo degradation by cytochrome P450 enzymes.


Patent
Sequoia Pharmaceuticals Inc. | Date: 2013-07-09

Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Pharmaceutical compositions are provided that can act as boosters to improve the pharmacokinetics, enhance the bioavailability, and enhance the therapeutic effect of drugs that undergo in vivo degradation by cytochrome P450 enzymes.


Trademark
Sequoia Pharmaceuticals Inc. | Date: 2008-02-28

Biochemical compounds, namely, assays and reagents for research and development in the fields of pharmaceuticals; biochemicals for general manufacturing of a wide variety of goods; biometallic compounds for use in the manufacture of pharmaceuticals. Pharmaceutical preparations for the treatment of infectious diseases. Pharmaceutical, chemical and biological product research and development services; screening of pharmaceuticals for therapeutic efficacy; pharmaceutical, chemical and biological product development consultation services.

Discover hidden collaborations